| Metric | Q3 2025 | Q2 2025 | Q3 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $700M | — | — | — | — |
| Op. Income | $172M | — | — | — | — |
| Gross Margin | 70.7% | — | — | — | — |
| Net Margin | 19.8% | — | — | — | — |
| EPS (Diluted) | $0.92 | — | — | — | — |
| Free Cash Flow | $256M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $700M |
| Cost of Revenue | $205M |
| GROSS PROFIT | $495M |
| R&D Expenses | $0 |
| Selling & Marketing | $146M |
| General & Administrative | $85M |
| SG&A Expenses | $230M |
| Other Expenses | $93M |
| Operating Expenses | $323M |
| Cost & Expenses | $528M |
| OPERATING INCOME | $172M |
| Interest Income | $0 |
| Interest Expense | $6M |
| Other Income/Expenses | $54M |
| INCOME BEFORE TAX | $226M |
| Income Tax Expense | $45M |
| Net Income from Continuing Ops | $181M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | -$3M |
| NET INCOME | $139M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $139M |
| D&A | $9M |
| EBIT | $172M |
| EBITDA | $181M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $700M |
| Cost of Revenue | $205M |
| GROSS PROFIT | $495M |
| R&D Expenses | $0 |
| Selling & Marketing | $146M |
| General & Administrative | $85M |
| SG&A Expenses | $230M |
| Other Expenses | $93M |
| Operating Expenses | $323M |
| Cost & Expenses | $528M |
| OPERATING INCOME | $172M |
| Interest Income | $0 |
| Interest Expense | $6M |
| Other Income/Expenses | $54M |
| INCOME BEFORE TAX | $226M |
| Income Tax Expense | $45M |
| Net Income from Continuing Ops | $181M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | -$3M |
| NET INCOME | $139M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $139M |
| D&A | $9M |
| EBIT | $172M |
| EBITDA | $181M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $139M |
| Depreciation & Amortization | $9M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $15M |
| Change in Working Capital | $95M |
| OPERATING CASH FLOW | $259M |
| Capital Expenditure | -$2M |
| Acquisitions (Net) | -$1M |
| Purchases of Investments | $506M |
| Sales/Maturities of Investments | -$3M |
| Other Investing Activities | -$467M |
| NET CASH FROM INVESTING | $39M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | -$67M |
| Common Dividends Paid | -$62M |
| Other Financing Activities | -$34M |
| NET CASH FROM FINANCING | -$163M |
| FREE CASH FLOW | $256M |
| Net Change in Cash | $129M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $1.0B |
| Short-Term Investments | $1.5B |
| Net Receivables | $470M |
| Inventory | $0 |
| Other Current Assets | $179M |
| TOTAL CURRENT ASSETS | $3.2B |
| PP&E (Net) | $35M |
| Goodwill | $1.6B |
| Intangible Assets | $2.5B |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | $274M |
| TOTAL NON-CURRENT ASSETS | $4.5B |
| TOTAL ASSETS | $7.6B |
| Account Payables | $348M |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $301M |
| TOTAL CURRENT LIABILITIES | $784M |
| Long-Term Debt | $395M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $575M |
| Other Non-Current Liabilities | $181M |
| TOTAL NON-CURRENT LIABILITIES | $1.2B |
| TOTAL LIABILITIES | $1.9B |
| Common Stock | $232M |
| Additional Paid-In Capital | $3.7B |
| Retained Earnings | $1.2B |
| Treasury Stock | -$1M |
| Accum. Other Comp. Income | -$348M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $4.8B |
| Minority Interest | $902M |
| TOTAL EQUITY | $5.7B |
| TOTAL LIABILITIES & EQUITY | $7.6B |
| Total Debt | $395M |
| Net Debt | -$646M |
